Langsung ke konten utama

Disney’S Panning For Gold

The Sunday Telegraph reports that Disney has pulled out of the novel live-action Peter Pan film only 5 weeks earlier its unloosen date. The determination is the termination of a row betwixt the studio too Great Ormond Street Hospital in London, which inherited the copyright in Peter Pan nether the volition of JM Barrie. Disney has argued that it should non convey to pay whatever royalties to the infirmary on the film-related merchandise that it sells since it has been making regular payments to secure the animated rights to the storey too has made voluntary payments from its income from merchandise associated amongst its animated “Peter Pan” film. Disney soundless feels that its partners inwards making the film, Sony too Revolution Studios, should convey to pay over a proportion of their merchandising profits.

is somewhat perturbed. While Great Ormond Street is undoubtedly the copyright holder inwards Peter Pan, the IPKat does non come across why this should automatically title it to merchandising rights inwards all things Peter Pan, unless we’re going to recognise copyright inwards names. Disney plans to merchandise books, board games, soft toys too reckoner games, but alone books actually demand making operate of Great Ormond Street’s copyright material. says that this is a merchandise grade or passing off issue, rather than a copyright issue.

Read the majority here
Sing similar Peter Pan here
Travel similar Peter Pan here
Act similar Peter Pan here

Komentar

Postingan populer dari blog ini

Something To Read This Weekend

July-August Copyright World The electrical flow termination of Informa's colourful Copyright World has only reached the IPKat. The comprehend story is Google v Rest of the World - at least, it must experience that means to the giant moneymaker every bit it seeks to induce got on a vast array of vested interests inwards mature markets as well as technologies amongst its controversial Library Project. bets that this topic volition attain saturation point, replacing fifty-fifty P2P filesharing every bit the boringly predictable PhD thesis topic that all candidates desire to write. Full listing of contents here . Merpel's Must-Read : "Into the Honey Trap?", where the Copyright Terminator meets Winnie the Pooh. July-August MIP The July-August termination of Euromoney's Managing Intellectual Property lists the 50 close influential IP personalities of the year. Alas, afterwards the excitement of making the listing concluding fourth dimension round, the IPKat has been ...

No Prophylactic Trend To Intermission Up; Latest Ecdr

No rubber agency to interruption up This morning time the IPKat carried a greenback on Scansafe Ltd 5 Messagelabs Ltd , a Chancery Division conclusion from Mr Justice Patten which was noted on Lawtel. has since received an electronic mail from solicitors acting on behalf of Scansafe, informing him that the Lawtel greenback erroneously stated that Scansafe's application for injunctive relief was dismissed. Lawtel has since withdrawn its greenback in addition to the IPKat, non wishing to mislead his readers, has removed his greenback on the example too. Latest ECDR Issue four of the Sweet & Maxwell bimonthly European Copyright in addition to Design Reports has at i time been published. Cases available inwards English linguistic communication inwards this lawsuit include * L'Oréal SA 5 Bellure NV (Cour d'appel de Paris), on the protection of scents inwards French Republic every bit authors' works; * PlayStation (Tribunal of Bolzano, Italy), on the seizure of modern...

Gsk Gets That Ill Feeling Equally Antibiotic Patents Come Across An Early On Death

GlaxoSmithKline ( lost its activity to forbid Swiss fellowship Novartis making in addition to selling inexpensive generic versions of Augmentin , GSK's leading antibiotic. GSK’s proceedings were aimed both against Novartis in addition to its generic company, Geneva Pharmaceuticals . The United States Court of Appeals for the Federal Circuit ruled inwards favour of Novartis in addition to Geneva slow on Friday, upholding Geneva's claim that vii of GSK's patents for the drug were "improper in addition to should non bring been used to extend patent protection for [GSK's] product". Novartis in addition to Geneva surprised the marketplace inwards 2002 when it launched a generic version of Augmentin. The launch came afterwards an unexpected United States legal determination inwards May 2002 that a position out of GSK's patents for Augmentin were invalid. GSK spent over a twelvemonth fighting the determination only the master copy ruling has straight off bee...